JV

John N. Vournakis

MT Marine Polymer Technologies: 40 patents #1 of 8Top 15%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
BH Brigham and Women's Hospital: 2 patents #490 of 1,764Top 30%
MD Musc Foundation For Research Development: 1 patents #114 of 264Top 45%
📍 Charleston, SC: #6 of 815 inventorsTop 1%
🗺 South Carolina: #132 of 15,501 inventorsTop 1%
Overall (All Time): #63,119 of 4,157,543Top 2%
46
Patents All Time

Issued Patents All Time

Showing 26–46 of 46 patents

Patent #TitleCo-InventorsDate
7115588 Methods for treating a breach or puncture in a blood vessel Sergio Finkielsztein 2006-10-03
7041657 Compositions and methods for modulation of vascular structure and/or function Sergio Finkielsztein 2006-05-09
6864245 Biocompatible poly-β-1→4-N-acetylglucosamine Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 2005-03-08
6743783 Pharmaceutical compositions comprising poly-&bgr;-1→4-N-acetylglucosamine Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 2004-06-01
6686342 Bicompatible poly-&bgr;-1→4-N-acetylglucosamine Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 2004-02-03
6649599 Methods and compositions for poly-&bgr;-1-4-N-acetylglucosamine cell therapy system Sergio Finkielstein, Ernest R. Pariser, Mike Helton 2003-11-18
6630459 Pharmaceutical compositions comprising poly-&bgr;-1→4-N-acetylglucosamine Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 2003-10-07
6610668 Methods and compositions for poly-&bgr;-1→4-N-acetylglucosamine cell therapy system Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 2003-08-26
6599720 Methods for making poly-&bgr;-1→4-N-acetylglucosamine Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 2003-07-29
6399328 Methods and compositions for diagnosis and treatment of breast cancer Arun K. Seth, Takis S. Papas 2002-06-04
6265548 Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence George N. Pavlakis, George A. Gaitanaris, Roland H. Stauber 2001-07-24
6063911 Methods and compositions for treatment of cell proliferative disorders Sergio Finkielsztein, Ernest R. Pariser 2000-05-16
6027881 Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence George N. Pavlakis, George A. Gaitanaris, Roland H. Stauber 2000-02-22
5858350 Methods and compositions for poly-.beta.-1.fwdarw.4-N-acetylglucosamine cell therapy system Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 1999-01-12
5846952 Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine drug delivery Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 1998-12-08
5686115 Poly-.beta.-1.fwdarw.4-N-acetylucosamine copolymer composition with collagen Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 1997-11-11
5635493 Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine chemotherapeutics Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 1997-06-03
5624679 Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine biological barriers Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 1997-04-29
5623064 Poly-.beta.-1.fwdarw.-4-N-acetylglucosamine Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 1997-04-22
5622834 Method of isolating poly-.beta.-1-4-N-acetylglucosamine from microalgal culture Sergio Finkielsztein, Ernest R. Pariser, Mike Helton 1997-04-22
5219749 Process for isolating and preparing purified chitin deacetylase Vassilis Bouriotis, Dimitri Kafetzopoulos 1993-06-15